Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas

被引：0

作者：

Frakulli, Rezarta ^{[1
]}

Salvi, Fabrizio ^{[2
]}

Balestrini, Damiano ^{[2
]}

Parisi, Alessandro ^{[2
]}

Palombarini, Marcella ^{[3
]}

Cammelli, Silvia ^{[1
]}

Rocca, Michele ^{[4
]}

Salone, Mariacristina ^{[4
]}

Longhi, Alessandra ^{[5
]}

Ferrari, Stefano ^{[5
]}

Morganti, Alessio G. ^{[1
]}

Frezza, Giovanni ^{[2
]}

机构：

[1] Univ Bologna, Dept Expt Diagnost & Specialty Med, Radiat Oncol Ctr, I-40138 Bologna, Italy

[2] Bellaria Hosp, Radiat Oncol Unit, Bologna, Italy

[3] Bellaria Hosp, Med Phys Unit, Bologna, Italy

[4] Rizzoli Orthopaed Inst, Gen & Thorac Surg, Bologna, Italy

[5] Rizzoli Orthopaed Inst, Dept Oncol, Bologna, Italy

来源：

ANTICANCER RESEARCH | 2015年 / 35卷 / 10期

关键词：

SBRT; sarcoma; lung metastases; PULMONARY METASTASES; SBRT;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: The purpose of this study was to evaluate local control and toxicity in a group of patients treated with stereotactic body radiotherapy (SBRT) for lung metastases (LM) from bone and soft tissue sarcomas. Patients and Methods: From October 2010 to July 2014, patients with LM from sarcomas not suitable for surgery were treated with daily cone-beam computed tomography-guided SBRT. The dose administered ranged from 30 to 60 Gy in 3-8 fractions. Acute and late toxicity were scored according to Common Terminology Criteria for Adverse Events version 4.0. Results: A total of 24 patients with 68 LM from sarcomas were treated with SBRT. The median follow-up after SBRT was 17 months (range=11-51 months). Two-year actuarial lesion local control and overall survival were 85.9% and 66.4%, respectively. No G3 or greater acute and late toxicities were observed. Conclusion: SBRT is a safe and effective treatment for LM from sarcoma and might be used as an alternative option in patients unfit for surgery.

引用

页码：5581 / 5586

页数：6

共 50 条

[41] Staging of Bone and Soft-tissue Sarcomas
Steffner, Robert J.
Jang, Eugene S.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2018, 26 (13) : E269 - E278
[42] PATHOLOGY OF BONE AND SOFT-TISSUE SARCOMAS
CONTESSO, G
COINDRE, JM
MAZABRAUD, A
BULLETIN DU CANCER, 1988, 75 (05) : 431 - 443
[43] Eleven Cases of Cardiac Metastases from Soft-tissue Sarcomas
Takenaka, Satoshi
Hashimoto, Nobuyuki
Araki, Nobuhito
Hamada, Kenichiro
Naka, Norifumi
Joyama, Susumu
Kakunaga, Shigeki
Ueda, Takafumi
Myoui, Akira
Yoshikawa, Hideki
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (04) : 514 - 518
[44] SIMULTANEOUS RADIOTHERAPY AND CHEMOTHERAPY OF SOFT-TISSUE SARCOMAS
PAPE, H
ZAMBOGLOU, N
FURST, G
SCHMITT, G
TUMORDIAGNOSTIK & THERAPIE, 1988, 9 : 31 - 34
[45] Stereotactic Body Radiotherapy (SBRT) for Metastatic and Recurrent Soft Tissue and Bone Sarcomas
Kim, E.
Jeans, E.
Shinohara, E. T.
Stavas, M. J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E754 - E754
[46] RADIATION-THERAPY IN THE TREATMENT OF BONE AND SOFT-TISSUE SARCOMAS
KALNICKI, S
ORTHOPEDIC CLINICS OF NORTH AMERICA, 1989, 20 (03) : 505 - 512
[47] Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
Spalek, Mateusz Jacek
Teterycz, Pawel
Borkowska, Aneta
Poleszczuk, Jan
Rutkowski, Piotr
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[48] Fulvestrant it the treatment patient with metastases in bone and soft-tissue
Wietrzynska, Justyna
ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : F8 - F9
[49] SYSTEMATIC COMBINATION OF RADIOTHERAPY AND SURGERY IN THE TREATMENT OF SOFT-TISSUE SARCOMAS IN ADULTS
ABBATUCCI, JS
LEVY, C
BOULIER, N
DERANIERI, J
MANDARD, AM
TANGUY, A
VERNHES, JC
LOZIER, JC
ANNALES DE RADIOLOGIE, 1989, 32 (02) : 117 - 122
[50] SURGICAL TREATMENT OF SOFT-TISSUE SARCOMAS
ECKERT, C
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1963, 184 (01): : 65 - &

← 1 2 3 4 5 →